Simplex Trading
MTCR

Simplex Trading’s Metacrine, Inc. Common Stock MTCR Stock Holding History

Simplex Trading’s Portfolio MTCR Stock Details MTCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,462
Closed -$1.29K – 11786
2021
Q4 		$1K Buy
+2,462
New +$4.39K ﹤0.01% 10315

Other funds holding MTCR

AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Simplex Trading's MTCR Position: Q1 2022 in Review

Simplex Trading sold out of Metacrine, Inc. Common Stock (MTCR) in Q1 2022, closing a stake of 2,462 shares — an estimated $1.29K sold.

Simplex Trading first reported a position in MTCR in Q4 2021 and held it in 1 quarter. The position peaked at $1K in Q4 2021. 31 funds tracked by Wall St. Rank hold MTCR as of Q1 2022.

  • Simplex Trading reported no remaining Metacrine, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Simplex Trading sold 2,462 Metacrine, Inc. Common Stock shares in Q1 2022, an estimated $1.29K.
  • Simplex Trading first reported a position in Metacrine, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Simplex Trading's Metacrine, Inc. Common Stock position peaked at $1K in Q4 2021.
  • 31 funds tracked by Wall St. Rank held Metacrine, Inc. Common Stock as of Q1 2022.

Based on Simplex Trading's 13F filing for Q1 2022, filed 2 May 2022.